AlphaYou
Overview
Smart money at a glance
Filings to Oct 12, 2026Net buying: insiders sold $0 and bought $200K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- +$200K netNet buying
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 1 added, 0 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 12- Open
- $49.98
- 52-wk high
- $58.90
- High
- $53.97
- 52-wk low
- $12.56
- Low
- $49.98
- Prev close
- $49.98
- Mkt cap
- $3.84B
- Volume
- 367.6K
- Beta
- 1.57
- P/S
- 3238.7x
- P/B
- 37.2x
- Profit margin
- +0.0%
- Op margin
- -5823.0%
- ROE
- -78.5%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about PLSE filings
Are insiders buying or selling Pulse Biosciences Inc (PLSE) stock?
Net buying: insiders sold $0 and bought $200K of PLSE stock on the open market in the 90 days to Oct 12, 2026, according to SEC Form 4 filings. The largest was Teplitsky, Liane Rae (Chief Operating Officer), who bought $200K. The latest filing was on Sep 2, 2026.
Which members of Congress have traded PLSE recently?
None. No member of Congress disclosed a PLSE trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this PLSE smart-money data?
This summary uses filings available on Oct 12, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net buying.
What funds are doing
Buys/Adds (1)
- BO
Bank of America
$21.4M
added
What insiders are doing
Buys (3)
- TL
Teplitsky Liane Rae
$100K
bought
- TL
Teplitsky Liane Rae
$100K
bought
- DR
Duggan Robert W
$13.0M
bought
How top traders are positioned
No tracked top-trader positions in PLSE right now.
Live Hyperliquid positioning - not every stock is covered
Activist stakes, short interest & more
Earnings
Earnings came in 16.1% below what analysts expected.
Last report
Aug 6, 2026
Period ending
Jun 30, 2026
Earnings per share
-$0.31 expected
Revenue
No reported revenue on record
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 6, 2026 | -$0.36 / -$0.31Alpha Vantage | -16.13% miss | Unavailable | Unavailable |
| Mar 31, 2026 | May 4, 2026 | -$0.24 / -$0.22Alpha Vantage | -9.73% miss | Unavailable | Unavailable |
| Dec 31, 2025 | Feb 19, 2026 | -$0.18 / -$0.21Alpha Vantage | +14.29% beat | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 5, 2025 | -$0.29 / -$0.31Alpha Vantage | +6.45% beat | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 12, 2025 | -$0.28 / -$0.26Alpha Vantage | -7.69% miss | Unavailable | Unavailable |
| Mar 31, 2025 | May 8, 2025 | Unavailable | - | Unavailable | Unavailable |
| Dec 31, 2024 | Mar 27, 2025 | -$0.31 / -$0.24Alpha Vantage | -30.17% miss | Unavailable | Unavailable |
| Sep 30, 2024 | Oct 30, 2024 | -$0.21 / -$0.24Alpha Vantage | +13.50% beat | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Reports Nov 4, 2026, in 23 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $86.0K | $264.0K | $401.0K | $434.0K |
| Cost of what it sold | $279.0K | $519.0K | $370.0K | $273.0K |
| Gross profit | -$193.0K | -$255.0K | $31.0K | $161.0K |
| What it spent | ||||
| Research and development | $11.4M | $10.9M | $12.6M | $17.0M |
| Sales and admin | $8.8M | $15.9M | $6.6M | $8.5M |
| Other operating costs | — | -$8.8M | — | — |
| Total operating expenses | $20.2M | $18.0M | $19.2M | $25.4M |
| What was left | ||||
| Operating profit | -$20.4M | -$18.3M | -$19.1M | -$25.3M |
| Profit before tax | -$19.4M | -$17.4M | -$18.6M | -$24.7M |
| Net profit | -$19.4M | -$17.4M | -$18.6M | -$24.7M |
| EBITDA | -$19.1M | -$17.2M | -$18.9M | -$24.4M |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace